Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the Registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the Registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company (as defined in Rule 12b-2 of the Securities Exchange Act of 1934). Large accelerated filer ¨ Accelerated filer x Non-accelerated filer ¨ Smaller reporting company ¨

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ¨ No x

Number of shares of the Registrant’s common stock outstanding on October 31, 2014: 48,682,884.

Items 2, 3, 4 and 5 of Part II are omitted because there is no information to report.

	December 31,		September 30,
	2013		2014
			(unaudited)
ASSETS
Current assets:
Cash and cash equivalents	$	52,609	$	72,503
Restricted cash and cash equivalents		3,343		3,880
Accounts and other receivables, net		10,632		12,310
Inventories, net		13,235		15,082
Prepaid expenses and other		809		794
Deferred income taxes		3,786		3,786

Total current assets		84,414		108,355

Other assets:
Marketable securities		252,677		93,855
Investment in Kronos Worldwide, Inc.		284,523		274,132
Goodwill		27,156		27,156
Other assets, net		2,707		3,137
Deferred income taxes		19		19

Total other assets		567,082		398,299

Property and equipment:
Land		5,138		5,138
Buildings		20,793		21,176
Equipment		58,195		61,834
Construction in progress		2,588		594

		86,714		88,742
Less accumulated depreciation		52,385		55,049

Net property and equipment		34,329		33,693

Total assets	$	685,825	$	540,347

	December 31,			September 30,
	2013			2014
				(unaudited)
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable	$	3,006		$	5,978
Accrued and other current liabilities		11,199			13,535
Accrued environmental remediation and related costs		4,859			12,681
Income taxes		6			15

Total current liabilities		19,070			32,209

Noncurrent liabilities:
Accrued pension cost		5,453			3,954
Accrued postretirement benefits (OPEB) costs		3,268			2,986
Accrued environmental remediation and related costs		108,777			104,289
Deferred income taxes		161,933			100,984
Other		18,329			18,295

Total noncurrent liabilities		297,760			230,508

Equity:
NL stockholders' equity:
Common stock		6,084			6,085
Additional paid-in capital		300,223			300,388
Retained earnings		84,089			107,205
Accumulated other comprehensive loss		(35,016	)		(150,331	)

Total NL stockholders' equity		355,380			263,347

Noncontrolling interest in subsidiary		13,615			14,283

Total equity		368,995			277,630

Total liabilities and equity	$	685,825		$	540,347

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2014			2013			2014
	(unaudited)

Net sales	$	24,209		$	26,473		$	69,701		$	79,102
Cost of sales		16,695			18,331			48,557			54,598

Gross margin		7,514			8,142			21,144			24,504

Selling, general and administrative expense		4,537			4,710			13,790			13,872
Other operating income (expense):
Insurance recoveries		2,198			8,843			3,774			10,041
Other income		9			9			23			140
Corporate expense and other, net		(5,627	)		(4,304	)		(26,869	)		(17,582	)

Income (loss) from operations		(443	)		7,980			(15,718	)		3,231

Equity in earnings (loss) of Kronos Worldwide, Inc.		(9,101	)		9,689			(31,891	)		24,101
Other income (expense):
Interest and dividend income		725			311			2,209			1,333
Interest expense		(10	)		-			(127	)		-

Income (loss) before income taxes		(8,829	)		17,980			(45,527	)		28,665

Income tax expense (benefit)		(3,145	)		3,800			(23,827	)		4,645

Net income (loss)		(5,684	)		14,180			(21,700	)		24,020
Noncontrolling interest in net income of subsidiary		256			291			613			904

Net income (loss) attributable to NL stockholders	$	(5,940	)	$	13,889		$	(22,313	)	$	23,116

Amounts attributable to NL stockholders:

Basic and diluted net income (loss) per share	$	(.12	)	$	.29		$	(.46	)	$	.47

Cash dividend per share	$	.125		$	-		$	.375		$	-

Weighted average shares used in the calculation of net income (loss) per share		48,674			48,683			48,671			48,678

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2014			2013			2014
	(unaudited)

Net income (loss)	$	(5,684	)	$	14,180		$	(21,700	)	$	24,020

Other comprehensive income (loss), net of tax:
Marketable securities		59,716			1,022			71,542			(105,842	)
Currency translation		4,155			(9,215	)		(119	)		(10,589	)
Defined benefit pension plans		692			530			2,078			1,585
Other postretirement benefit plans		(144	)		(156	)		(432	)		(469	)

Total other comprehensive income (loss), net		64,419			(7,819	)		73,069			(115,315	)

Comprehensive income (loss)		58,735			6,361			51,369			(91,295	)
Comprehensive income attributable to noncontrolling interest		256			291			613			904

Comprehensive income (loss) attributable to NL stockholders	$	58,479		$	6,070		$	50,756		$	(92,199	)

							Accumulated
			Additional				other			Noncontrolling
	Common		paid-in		Retained		comprehensive			interest in			Total
	stock		capital		earnings		loss			subsidiary			equity
	(unaudited)

Balance at December 31, 2013	$	6,084	$	300,223	$	84,089	$	(35,016	)	$	13,615		$	368,995

Net income		-		-		23,116		-			904			24,020
Other comprehensive loss, net of tax		-		-		-		(115,315	)		-			(115,315	)
Issuance of NL common stock		1		76		-		-			-			77
Dividends		-		-		-		-			(246	)		(246	)
Other, net		-		89		-		-			10			99

Balance at September 30, 2014	$	6,085	$	300,388	$	107,205	$	(150,331	)	$	14,283		$	277,630

	Nine months ended
	September 30,
	2013			2014
	(unaudited)
Cash flows from operating activities:
Net income (loss)	$	(21,700	)	$	24,020
Depreciation and amortization		2,513			2,694
Deferred income taxes		(21,651	)		1,132
Equity in (earnings) loss of Kronos Worldwide, Inc.		31,891			(24,101	)
Distributions from Kronos Worldwide, Inc.		15,849			15,849
Cash funding of benefit plans in excess of net benefit plan expense		(895	)		(2,145	)
Other, net		263			417
Change in assets and liabilities:
Accounts and other receivables, net		(3,661	)		(1,839	)
Inventories, net		(1,884	)		(2,030	)
Prepaid expenses and other		171			15
Accounts payable and accrued liabilities		100			2,184
Income taxes		(6	)		3
Accounts with affiliates		(2,467	)		3,380
Accrued environmental remediation and related costs		10,007			3,334
Other noncurrent assets and liabilities, net		(1,169	)		(63	)

Net cash provided by operating activities		7,361			22,850

Cash flows from investing activities:
Capital expenditures		(2,589	)		(2,199	)
Change in restricted cash equivalents, net		2,007			(454	)
Collection of note receivable		3,034			-
Proceeds from the disposal of:
Assets held for sale		1,559			-
Marketable securities		272			-
Purchase of marketable securities		(261	)		-
Other		(94	)		(57	)

Net cash provided by (used in) investing activities		3,928			(2,710	)

	Nine months ended
	September 30,
	2013			2014
	(unaudited)

Cash flows from financing activities:
Cash dividends paid	$	(18,252	)	$	-
Distributions to noncontrolling interests in subsidiary		(369	)		(246	)
Repayments of indebtedness		(18,480	)		-

Net cash used in financing activities		(37,101	)		(246	)

Cash and cash equivalents - net change from:
Operating, investing and financing activities		(25,812	)		19,894
Cash and cash equivalents at beginning of period		77,987			52,609

Cash and cash equivalents at end of period	$	52,175		$	72,503

Supplemental disclosures:
Cash paid for:
Interest	$	222		$	-
Income taxes, net		296			190

Organization - At September 30, 2014, (i) Valhi, Inc. (NYSE: VHI) held approximately 83% of our outstanding common stock and (ii) a wholly-owned subsidiary of Contran Corporation held approximately 94% of Valhi’s outstanding common stock. Substantially all of Contran’s outstanding voting stock is held by family trusts established for the benefit of Lisa K. Simmons and Serena Simmons Connelly, daughters of Harold C. Simmons, and their children (for which Ms. Lisa Simmons and Ms. Connelly are co-trustees) or is held directly by Ms. Lisa Simmons and Ms. Connelly or persons or entities related to them, including their step-mother Annette C. Simmons, the widow of Mr. Simmons. Prior to his death in December 2013, Mr. Simmons served as sole trustee of the family trusts. Under a voting agreement entered into by all of the voting stockholders of Contran, effective in February 2014 and as amended, the size of the board of directors of Contran was fixed at five members, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons (and in the event of their death, their heirs) each has the right to designate one of the five members of the Contran board and the remaining two members of the Contran board must consist of members of Contran management. Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons each serve as members of the Contran board. The voting agreement expires in February 2017 (unless Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons otherwise unanimously agree), and the ability of Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons to each designate one member of the Contran board is dependent upon each of their continued beneficial ownership of at least 5% of the combined voting stock of Contran. Consequently, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons may be deemed to control Contran, Valhi and us.

Basis of presentation - Consolidated in this Quarterly Report are the results of our majority-owned subsidiary, CompX International Inc. We also own 30% of Kronos Worldwide, Inc. (Kronos). CompX (NYSE MKT: CIX) and Kronos (NYSE: KRO); each file periodic reports with the Securities and Exchange Commission (SEC).

The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2013 that we filed with the SEC on March 12, 2014 (the 2013 Annual Report). In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented. We have condensed the Consolidated Balance Sheet and Statement of Stockholders’ Equity at December 31, 2013 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2013) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). Our results of operations for the interim periods ended September 30, 2014 may not be indicative of our operating results for the full year. The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2013 Consolidated Financial Statements contained in our 2013 Annual Report.

In February 2014, our Board of Directors deferred consideration of a first quarter 2014 cash dividend, and no dividend was paid in the first quarter. In May 2014, after considering our results of operations, financial conditions and cash requirements for our businesses, our Board of Directors suspended our regular quarterly dividend. The declaration and payment of future dividends, and the amount thereof, is discretionary and is dependent upon these and other factors deemed relevant by our Board of Directors.

Unless otherwise indicated, references in this report to “NL,” “we,” “us” or “our” refer to NL Industries, Inc. and its subsidiaries and affiliate, Kronos, taken as a whole.

At December 31, 2013 and September 30, 2014, we held approximately 14.4 million shares of common stock of our immediate parent company, Valhi. We account for our investment in Valhi common stock as available-for-sale marketable equity securities and any unrealized gains or losses on the securities are recognized through other comprehensive income, net of deferred income taxes. Our shares of Valhi common stock are carried at fair value based on quoted market prices, representing a Level 1 input within the fair value hierarchy. At December 31, 2013 and September 30, 2014, the quoted per share market price of Valhi common stock was $17.58 and $6.53, respectively.

The Valhi common stock we own is subject to the restrictions on resale pursuant to certain provisions of the SEC Rule 144. In addition, as a majority-owned subsidiary of Valhi, we cannot vote our shares of Valhi common stock under Delaware Corporation Law, but we do receive dividends from Valhi on these shares, when declared and paid.

At December 31, 2013 and September 30, 2014, we owned approximately 35.2 million shares of Kronos common stock. At September 30, 2014, the quoted market price of Kronos’ common stock was $13.78 per share, or an aggregate market value of $485.3 million. At December 31, 2013, the quoted market price was $19.05 per share, or an aggregate market value of $670.9 million.

The change in the carrying value of our investment in Kronos during the first nine months of 2014 is summarized below. See also Note 12.

	December 31,		September 30,
	2013		2014
	(In millions)
Current assets	$	781.2	$	897.6
Property and equipment, net		536.3		500.8
Investment in TiO₂ joint venture		102.3		89.1
Other noncurrent assets		199.3		163.9

Total assets	$	1,619.1	$	1,651.4

Current liabilities	$	278.0	$	211.3
Long-term debt		180.4		345.7
Accrued pension and postretirement benefits		171.6		152.0
Other noncurrent liabilities		54.0		41.5
Stockholders' equity		935.1		900.9

Total liabilities and stockholders' equity	$	1,619.1	$	1,651.4

During the first nine months of 2014, we had no borrowings under our promissory note with Valhi, and at September 30, 2014, the full $40 million was available for borrowing under this facility. The amount of any such loan Valhi would make to us is at Valhi’s discretion.

Defined benefit plans - The components of net periodic defined benefit pension cost (income) are presented in the table below.

Postretirement benefits - The components of net periodic postretirement benefits other than pension (OPEB) income are presented in the table below.

Contributions - We currently expect our 2014 contributions to our defined benefit pension plans and other postretirement plans to be approximately $2 million.

Changes in accumulated other comprehensive loss attributable to NL stockholders for the three and nine months ended September 30, 2013 and 2014 are presented in the table below.

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2014			2013			2014
	(In thousands)
Accumulated other comprehensive loss, net of tax:
Marketable securities:
Balance at beginning of period	$	117,245		$	47,305		$	105,419		$	154,169
Other comprehensive income (loss) -
unrealized gains (losses) arising during the year		59,716			1,022			71,542			(105,842	)

Balance at end of period	$	176,961		$	48,327		$	176,961		$	48,327

Currency translation:
Balance at beginning of period	$	(139,439	)	$	(135,190	)	$	(135,165	)	$	(133,816	)
Other comprehensive income (loss)		4,155			(9,215	)		(119	)		(10,589	)

Balance at end of period	$	(135,284	)	$	(144,405	)	$	(135,284	)	$	(144,405	)

Defined benefit pension plans:
Balance at beginning of period	$	(65,016	)	$	(55,589	)	$	(66,402	)	$	(56,644	)
Other comprehensive income -
amortization of net losses
included in net periodic pension cost		692			530			2,078			1,585

Balance at end of period	$	(64,324	)	$	(55,059	)	$	(64,324	)	$	(55,059	)

OPEB plans:
Balance at beginning of period	$	607		$	962		$	895		$	1,275
Other comprehensive loss -
amortization of prior service credit and net gains
included in net periodic OPEB cost		(144	)		(156	)		(432	)		(469	)

Balance at end of period	$	463		$	806		$	463		$	806

Total accumulated other comprehensive loss:
Balance at beginning of period	$	(86,603	)	$	(142,512	)	$	(95,253	)	$	(35,016	)
Other comprehensive income (loss)		64,419			(7,819	)		73,069			(115,315	)

Balance at end of period	$	(22,184	)	$	(150,331	)	$	(22,184	)	$	(150,331	)

See Note 10 for amounts related to our defined benefit pension plans and OPEB plans.

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2014			2013			2014
	(In millions)
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$	(3.1	)	$	6.3		$	(15.9	)	$	10.0
Incremental U.S. tax and rate differences on equity in earnings		-			(2.5	)		(7.4	)		(5.8	)
Nontaxable income		(.1	)		.2			(.8	)		(.1	)
U.S. state income taxes and other, net		.1			(.2	)		.3			.5

Total	$	(3.1	)	$	3.8		$	(23.8	)	$	4.6

	Three months ended						Nine months ended
	September 30,						September 30,
	2013			2014			2013			2014
	(In millions)
Comprehensive provision (benefit) for income taxes allocable to:
Net income (loss)	$	(3.1	)	$	3.8		$	(23.8	)	$	4.6
Other comprehensive income (loss):
Marketable securities		32.1			.5			38.5			(57.0	)
Currency translation		2.2			(5.0	)		(.1	)		(5.7	)
Pension plans		.4			.3			1.1			.9
OPEB plans		(.1	)		(.1	)		(.2	)		(.3	)

Total	$	31.5		$	(.5	)	$	15.5		$	(57.5	)

Tax authorities are examining certain of our U.S. and non-U.S. tax returns, including those of Kronos, and tax authorities have or may propose tax deficiencies, including penalties and interest. We cannot guarantee these tax matters will be resolved in our favor due to the inherent uncertainties involved in settlement initiatives and court and tax proceedings. We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations. We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity.

In 2011 and 2012, Kronos received notices of re-assessment from the Canadian federal and provincial tax authorities related to the years 2002 through 2004. Kronos objected to the re-assessments and believed the position was without merit. In the second quarter of 2014, the Appeals Division of the Canadian Revenue Authority ruled in Kronos’ favor and reversed in their entirety such notices of reassessment. As a result, Kronos recognized a non-cash income tax benefit of $3.0 million related to the release of a portion of its reserve for uncertain tax positions in the second quarter of 2014 related to the completion of this Canadian income tax audit. Also during the second quarter of 2014, Kronos recognized a non-cash income tax benefit of $3.1 million related to the release of a portion of its reserve for uncertain tax positions in conjunction with the completion of an audit of its U.S. income tax return for 2009.

Our 2014 provision for income taxes includes a first quarter $.4 million provision which is a correction of amounts that should have been recognized in the fourth quarter of 2012 and is not material to any current or prior periods.

We currently estimate that our unrecognized tax benefits will decrease by approximately $4.6 million during the next twelve months due to the expiration of certain statutes of limitation.

Our former operations included the manufacture of lead pigments for use in paint and lead-based paint. We, other former manufacturers of lead pigments for use in paint and lead-based paint (together, the “former pigment manufacturers”), and the Lead Industries Association (LIA), which discontinued business operations in 2002, have been named as defendants in various legal proceedings seeking damages for personal injury, property damage and governmental expenditures allegedly caused by the use of lead-based paints. Certain of these actions have been filed by or on behalf of states, counties, cities or their public housing authorities and school districts, and certain others have been asserted as class actions. These lawsuits seek recovery under a variety of theories, including public and private nuisance, negligent product design, negligent failure to warn, strict liability, breach of warranty, conspiracy/concert of action, aiding and abetting, enterprise liability, market share or risk contribution liability, intentional tort, fraud and misrepresentation, violations of state consumer protection statutes, supplier negligence and similar claims.

The plaintiffs in these actions generally seek to impose on the defendants responsibility for lead paint abatement and health concerns associated with the use of lead-based paints, including damages for personal injury, contribution and/or indemnification for medical expenses, medical monitoring expenses and costs for educational programs. To the extent the plaintiffs seek compensatory or punitive damages in these actions, such damages are generally unspecified. In some cases, the damages are unspecified pursuant to the requirements of applicable state law. A number of cases are inactive or have been dismissed or withdrawn. Most of the remaining cases are in various pre-trial stages. Some are on appeal following dismissal or summary judgment rulings in favor of either the defendants or the plaintiffs. In addition, various other cases (in which we are not a defendant) are pending that seek recovery for injury allegedly caused by lead pigment and lead-based paint. Although we are not a defendant in these cases, the outcome of these cases may have an impact on cases that might be filed against us in the future.

We believe that these actions are without merit, and we intend to continue to deny all allegations of wrongdoing and liability and to defend against all actions vigorously. We do not believe it is probable that we have incurred any liability with respect to all of the lead pigment litigation cases to which we are a party, and liability to us that may result, if any, in this regard cannot be reasonably estimated, because:

Accordingly, we have not accrued any amounts for any of the pending lead pigment and lead-based paint litigation cases filed by or on behalf of states, counties, cities or their public housing authorities and school districts, or those asserted as class actions. In addition, we have determined that liability to us which may result, if any, cannot be reasonably estimated because there is no prior history of a loss of this nature on which an estimate could be made and there is no substantive information available upon which an estimate could be based.

In one of these lead pigment cases, in April 2000 we were served with a complaint (County of Santa Clara v. Atlantic Richfield Company, et al, Superior Court of the State of California, County of Santa Clara, Case No. 1-00-CV-788657) brought by a number of California government entities against the former pigment manufacturers, the LIA and certain paint manufacturers. The County of Santa Clara sought to recover compensatory damages for funds the plaintiffs had expended or would in the future expend for medical treatment, educational expenses, abatement or other costs due to exposure to, or potential exposure to, lead paint, disgorgement of profit, and punitive damages. In July 2003, the trial judge granted defendants’ motion to dismiss all remaining claims. Plaintiffs appealed and the intermediate appellate court reinstated public nuisance, negligence, strict liability, and fraud claims in March 2006. A fourth amended complaint was filed in March 2011 on behalf of The People of California by the County Attorneys of Alameda, Ventura, Solano, San Mateo, Los Angeles and Santa Clara, and the City Attorneys of San Francisco, San Diego and Oakland. That complaint alleged that the presence of lead paint created a public nuisance in each of the prosecuting jurisdictions and sought its abatement. In July and August 2013, the case was tried. In January 2014, the Court issued a judgment finding us, The Sherwin Williams Company and ConAgra jointly and severally liable for the abatement of lead paint in pre-1980 homes, and ordered the defendants to pay an aggregate $1.15 billion to the people of the State of California to fund such abatement. In February 2014, we filed a motion for a new trial, and in March 2014 the court denied the motion. Subsequently in March 2014, we filed a notice of appeal with the Sixth District Court of Appeal for the State of California and the appeal is proceeding with the appellate court. NL believes that this judgment is inconsistent with California law and is unsupported by the evidence, and we will defend vigorously against all claims.

The Santa Clara case is unusual in that this is the second time that an adverse verdict in the lead pigment litigation has been entered against NL (the first adverse verdict against NL was ultimately overturned on appeal). We have concluded that the likelihood of a loss in this case has not reached a standard of “probable” as contemplated by ASC 450, given (i) the substantive, substantial and meritorious grounds on which the adverse verdict in the Santa Clara case will be appealed, (ii) the uniqueness of the Santa Clara verdict (i.e. no final, non-appealable verdicts have ever been rendered against us, or any of the other former lead pigment manufacturers, based on the public nuisance theory of liability or otherwise), and (iii) the rejection of the public nuisance theory of liability as it relates to lead pigment matters in many other jurisdictions (no jurisdiction in which a plaintiff has asserted a public nuisance theory of liability has ever successfully been upheld). In addition, liability that may result, if any, cannot be reasonably estimated, as NL continues to have no basis on which an estimate of liability could be made, as discussed above. However, as with any legal proceeding, there is no assurance that any appeal would be successful, and it is reasonably possible, based on the outcome of the appeals process, that NL may in the future incur some liability resulting in the recognition of a loss contingency accrual that could have a material adverse impact on our results of operations, financial position and liquidity.

New cases may continue to be filed against us. We cannot assure you that we will not incur liability in the future in respect of any of the pending or possible litigation in view of the inherent uncertainties involved in court and jury rulings. In the future, if new information regarding such matters becomes available to us (such as a final, non-appealable adverse verdict against us or otherwise ultimately being found liable with respect to such matters), at that time we would consider such information in evaluating any remaining cases then-pending against us as to whether it might then have become probable we have incurred liability with respect to these matters, and whether such liability, if any, could have become reasonably estimable. The resolution of any of these cases could result in the recognition of a loss contingency accrual that could have a material adverse impact on our net income for the interim or annual period during which such liability is recognized and a material adverse impact on our consolidated financial condition and liquidity.

Our operations are governed by various environmental laws and regulations. Certain of our businesses are and have been engaged in the handling, manufacture or use of substances or compounds that may be considered toxic or hazardous within the meaning of applicable environmental laws and regulations. As with other companies engaged in similar businesses, certain of our past and current operations and products have the potential to cause environmental or other damage. We have implemented and continue to implement various policies and programs in an effort to minimize these risks. Our policy is to maintain compliance with applicable environmental laws and regulations at all of our plants and to strive to improve environmental performance. From time to time, we may be subject to environmental regulatory enforcement under U.S. and non-U.S. statutes, the resolution of which typically involves the establishment of compliance programs. It is possible that future developments, such as stricter requirements of environmental laws and enforcement policies, could adversely affect our production, handling, use, storage, transportation, sale or disposal of such substances. We believe that all of our facilities are in substantial compliance with applicable environmental laws.

Certain properties and facilities used in our former operations, including divested primary and secondary lead smelters and former mining locations, are the subject of civil litigation, administrative proceedings or investigations arising under federal and state environmental laws and common law. Additionally, in connection with past operating practices, we are currently involved as a defendant, potentially responsible party (PRP) or both, pursuant to the Comprehensive Environmental Response, Compensation and Liability Act, as amended by the Superfund Amendments and Reauthorization Act (CERCLA), and similar state laws in various governmental and private actions associated with waste disposal sites, mining locations, and facilities that we or our predecessors, our subsidiaries or their predecessors currently or previously owned, operated or used, certain of which are on the United States Environmental Protection Agency’s (EPA) Superfund National Priorities List or similar state lists. These proceedings seek cleanup costs, damages for personal injury or property damage and/or damages for injury to natural resources. Certain of these proceedings involve claims for substantial amounts. Although we may be jointly and severally liable for these costs, in most cases we are only one of a number of PRPs who may also be jointly and severally liable, and among whom costs may be shared or allocated. In addition, we are also a party to a number of personal injury lawsuits filed in various jurisdictions alleging claims related to environmental conditions alleged to have resulted from our operations.

Obligations associated with environmental remediation and related matters are difficult to assess and estimate for numerous reasons including the:

In addition, the imposition of more stringent standards or requirements under environmental laws or regulations, new developments or changes regarding site cleanup costs or the allocation of costs among PRPs, solvency of other PRPs, the results of future testing and analysis undertaken with respect to certain sites or a determination that we are potentially responsible for the release of hazardous substances at other sites, could cause our expenditures to exceed our current estimates. We cannot assure you that actual costs will not exceed accrued amounts or the upper end of the range for sites for which estimates have been made, and we cannot assure you that costs will not be incurred for sites where no estimates presently can be made. Further, additional environmental and related matters may arise in the future. If we were to incur any future liability, this could have a material adverse effect on our consolidated financial statements, results of operations and liquidity.

We record liabilities related to environmental remediation and related matters (including costs associated with damages for personal injury or property damage and/or damages for injury to natural resources) when estimated future expenditures are probable and reasonably estimable. We adjust such accruals as further information becomes available to us or as circumstances change. Unless the amounts and timing of such estimated future expenditures are fixed and reasonably determinable, we generally do not discount estimated future expenditures to their present value due to the uncertainty of the timing of the payout. We recognize recoveries of costs from other parties, if any, as assets when their receipt is deemed probable. At December 31, 2013 and September 30, 2014, we have not recognized any receivables for recoveries.

We do not know and cannot estimate the exact time frame over which we will make payments for our accrued environmental and related costs. The timing of payments depends upon a number of factors, including but not limited to the timing of the actual remediation process; which in turn depends on factors outside of our control. At each balance sheet date, we estimate the amount of our accrued environmental and related costs which we expect to pay within the next twelve months, and we classify this estimate as a current liability. We classify the remaining accrued environmental costs as a noncurrent liability.

Changes in the accrued environmental remediation and related costs during the first nine months of 2014 are as follows:

On a quarterly basis, we evaluate the potential range of our liability for environmental remediation and related costs at sites where we have been named as a PRP or defendant, including sites for which our wholly-owned environmental management subsidiary, NL Environmental Management Services, Inc. (EMS), has contractually assumed our obligations. At September 30, 2014, we had accrued approximately $117 million related to approximately 45 sites associated with remediation and related matters that we believe are at the present time and/or in their current phase reasonably estimable. The upper end of the range of reasonably possible costs to us for remediation and related matters for which we believe it is possible to estimate costs is approximately $156 million, including the amount currently accrued.

We believe that it is not reasonably possible to estimate the range of costs for certain sites. At September 30, 2014, there were approximately 5 sites for which we are not currently able to reasonably estimate a range of costs. For these sites, generally the investigation is in the early stages, and we are unable to determine whether or not we actually had any association with the site, the nature of our responsibility, if any, for the contamination at the site and the extent of contamination at and cost to remediate the site. The timing and availability of information on these sites is dependent on events outside of our control, such as when the party alleging liability provides information to us. At certain of these previously inactive sites, we have received general and special notices of liability from the EPA and/or state agencies alleging that we, sometimes with other PRPs, are liable for past and future costs of remediating environmental contamination allegedly caused by former operations. These notifications may assert that we, along with any other alleged PRPs, are liable for past and/or future clean-up costs. As further information becomes available to us for any of these sites, which would allow us to estimate a range of costs, we would at that time adjust our accruals. Any such adjustment could result in the recognition of an accrual that would have a material effect on our consolidated financial statements, results of operations and liquidity.

We are involved in certain legal proceedings with a number of our former insurance carriers regarding the nature and extent of the carriers’ obligations to us under insurance policies with respect to certain lead pigment and asbestos lawsuits. The issue of whether insurance coverage for defense costs or indemnity or both will be found to exist for our lead pigment and asbestos litigation depends upon a variety of factors and we cannot assure you that such insurance coverage will be available.

We have agreements with certain of our former insurance carriers pursuant to which the carriers reimburse us for a portion of our future lead pigment litigation defense costs, and one such carrier reimburses us for a portion of our future asbestos litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. While we continue to seek additional insurance recoveries, we do not know if we will be successful in obtaining reimbursement for either defense costs or indemnity. Accordingly, we recognize insurance recoveries in income only when receipt of the recovery is probable and we are able to reasonably estimate the amount of the recovery.

For a complete discussion of certain litigation involving us and certain of our former insurance carriers, refer to our 2013 Annual Report.

We have been named as a defendant in various lawsuits in several jurisdictions, alleging personal injuries as a result of occupational exposure primarily to products manufactured by our former operations containing asbestos, silica and/or mixed dust. In addition, some plaintiffs allege exposure to asbestos from working in various facilities previously owned and/or operated by us. There are 1,130 of these types of cases pending, involving a total of approximately 1,643 plaintiffs. In addition, the claims of approximately 8,298 plaintiffs have been administratively dismissed or placed on the inactive docket in Ohio, Indiana and Texas state courts. We do not expect these claims will be re-opened unless the plaintiffs meet the courts’ medical criteria for asbestos-related claims. We have not accrued any amounts for this litigation because of the uncertainty of liability and inability to reasonably estimate the liability, if any. To date, we have not been adjudicated liable in any of these matters. Based on information available to us, including:

We believe that the range of reasonably possible outcomes of these matters will be consistent with our historical costs (which are not material). Furthermore, we do not expect any reasonably possible outcome would involve amounts material to our consolidated financial position, results of operations or liquidity. We have sought and will continue to vigorously seek, dismissal and/or a finding of no liability from each claim. In addition, from time to time, we have received notices regarding asbestos or silica claims purporting to be brought against former subsidiaries, including notices provided to insurers with which we have entered into settlements extinguishing certain insurance policies. These insurers may seek indemnification from us. For a discussion of other legal proceedings to which we are a party, refer to our 2013 Annual Report.

In addition to the litigation described above, we and our affiliate are also involved in various other environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to present and former businesses. In certain cases, we have insurance coverage for these items, although we do not expect additional material insurance coverage for environmental matters.

We currently believe the disposition of all of these various other claims and disputes, individually and in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals already provided.

See Note 4 for information on how we determine fair value of our marketable securities.

The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure at December 31, 2013 and September 30, 2014:

The fair value of our noncontrolling interest in CompX and NL stockholder’s equity is based upon quoted market prices at each balance sheet date, which represent Level 1 inputs as defined by ASC Topic 820-10-35. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value.

In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606). This standard replaces existing revenue recognition guidance, which in many cases was tailored for specific industries, with a uniform accounting standard applicable to all industries and transactions. The new standard is effective for us beginning with the first quarter of 2017. Entities may elect to adopt ASU No. 2014-09 retrospectively for all periods for all contracts and transactions which occurred during the period (with a few exceptions for practical expediency) or retrospectively with a cumulative effect recognized as of the date of adoption. ASU No. 2014-09 is a fundamental rewriting of existing GAAP with respect to revenue recognition, and we are evaluating the effect the Standard will have on our Consolidated Financial Statements. In addition, we have not yet determined the method we will use to adopt the Standard.

We are primarily a holding company. We operate in the component products industry through our majority-owned subsidiary, CompX International Inc. We also own a non-controlling interest in Kronos Worldwide, Inc. Both CompX (NYSE MKT: CIX) and Kronos (NYSE: KRO) file periodic reports with the Securities and Exchange Commission (SEC).

CompX is a leading manufacturer of engineered components utilized in a variety of applications and industries. Through its Security Products operations, CompX manufactures mechanical and electronic cabinet locks and other locking mechanisms used in recreational transportation, postal, office and institutional furniture, cabinetry, tool storage and healthcare applications. CompX also manufactures stainless steel exhaust systems, gauges and throttle controls for the recreational marine and other industries through its Marine Components operations.

We account for our 30% non-controlling interest in Kronos by the equity method. Kronos is a leading global producer and marketer of value-added titanium dioxide pigments (TiO₂). TiO₂ is used for a variety of manufacturing applications including coatings, plastics, paper and other industrial and specialty products.

This report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Statements in this Quarterly Report on Form 10-Q that are not historical facts are forward-looking in nature and represent management’s beliefs and assumptions based on currently available information. Statements in this report including, but not limited to, the statements found in Item 2 - “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” are forward-looking statements that represent our management’s beliefs and assumptions based on currently available information. In some cases you can identify these forward-looking statements by the use of words such as “believes,” “intends,” “may,” “should,” “could,” “anticipates,” “expects” or comparable terminology, or by discussions of strategies or trends. Although we believe the expectations reflected in forward-looking statements are reasonable, we do not know if these expectations will be correct. Such statements by their nature involve substantial risks and uncertainties that could significantly impact expected results. Actual future results could differ materially from those predicted. The factors that could cause our actual future results to differ materially from those described herein are the risks and uncertainties discussed in this Quarterly Report and those described from time to time in our other filings with the SEC, which include, but are not limited to, the following:

Should one or more of these risks materialize (or if the consequences of such a development worsen), or should the underlying assumptions prove incorrect, actual results could differ materially from those currently forecasted or expected. We disclaim any intention or obligation to update or revise any forward-looking statement whether as a result of changes in information, future events or otherwise.

Quarter ended September 30, 2014 compared to the quarter ended September 30, 2013

Our net income attributable to NL stockholders was $13.9 million, or $.29 per share, in the third quarter of 2014 compared to a net loss attributable to NL stockholders of $5.9 million, or $.12 per share, in the third quarter of 2013.

As more fully described below, the increase in our earnings per share from 2013 to 2014 is primarily due to:

Our 2014 net income attributable to NL stockholders includes income of $.12 per share, net of income taxes, related to insurance recoveries we recognized.

Nine months ended September 30, 2014 compared to nine months ended September 30, 2013

Our net income attributable to NL stockholders was $23.1 million or $.47 per share in the first nine months of 2014 compared to a net loss attributable to NL stockholders of $22.3 million or $.46 per share, in the first nine months of 2013.

As more fully described below, the increase in our earnings per share from 2013 to 2014 is primarily related to

	Three months ended September 30,						% Change			Nine months ended September 30,						% Change
	2013			2014			% Change			2013			2014			% Change
	(In millions)
CompX	$	3.0		$	3.4			13	%	$	7.3		$	10.6			45	%
Insurance recoveries		2.2			8.8			300	%		3.8			10.0			163	%
Other income		-			-			-			-			.1			n.m.
Corporate expense and other, net		(5.6	)		(4.3	)		(23	)%		(26.8	)		(17.5	)		(35	)%
Income (loss) from operations	$	(.4	)	$	7.9					$	(15.7	)	$	3.2

Amounts attributable to CompX relate to its components products business, while the other amounts generally relate to NL. Each of these items is further discussed below.

The following table shows the components of our income (loss) before income taxes exclusive of our loss from operations.

	Three months ended September 30,						% Change			Nine months ended September 30,							% Change
	2013			2014			% Change			2013			2014				% Change
	(In thousands)
Net sales	$	24,209		$	26,473			9	%	$	69,701			$	79,102			13	%
Cost of sales		16,695			18,331			10	%		48,557				54,598			12	%
Gross margin		7,514			8,142			8	%		21,144				24,504			16	%
Operating costs and expenses		(4,537	)		(4,710	)		4	%		(13,790	)			(13,872	)		1	%
Income from operations	$	2,977		$	3,432			15	%	$	7,354			$	10,632			45	%
Percentage of net sales:
Cost of sales		69	%		69	%					70	%			69	%
Gross margin		31	%		31	%					30	%			31	%
Income from operations		12	%		13	%					10	%			13	%

Net sales - Net sales increased $2.3 million in the third quarter of 2014 and $9.4 million in the first nine months of 2014 compared to the same periods in 2013, led by strong demand within CompX’s Security Products business, including a new initiative for an existing government customer, increased market penetration in electronic locks and strong demand in transportation markets. Sales from CompX’s Marine Components business also contributed to the increase, reflecting greater penetration into non high-performance marine markets. Relative changes in selling prices did not have a material impact on net sales comparisons.

Cost of sales and gross margin - As a percentage of net sales, cost of sales in the third quarter of 2014 is comparable to the third quarter of 2013 as improved coverage of fixed manufacturing costs over increased production volumes was offset by the impact of a lower variable contribution margin due to relative changes in customer and product mix. As a result, gross margin as a percentage of net sales was comparable over the same period, while gross margin increased by $.6 million due to higher sales. Cost of sales as a percentage of sales decreased by approximately 1% for the first nine months of 2014, primarily due to improved coverage of fixed manufacturing costs over increased production volumes to meet higher demand for CompX’s products, partially offset by the impact of lower variable margins due to relative changes in customer and product mix within CompX’s Security Products business and slightly increased medical expenses for the nine month period (most of which relates to the first half of the year). As a result, gross margin and gross margin as a percentage of net sales increased over the same period.

Operating costs and expenses - Operating costs and expenses consist primarily of sales and administrative related personnel costs, sales commissions and advertising expenses, as well as gains and losses on plant, property and equipment. Operating costs and expenses in the third quarter of 2014 are comparable to the same period in 2013 and increased slightly in the third quarter and the first nine months of 2014 as compared to the same period in 2013 primarily as a result of increased administrative personnel costs and increased depreciation for CompX’s Security Products business, partially offset by reduced corporate administrative personnel costs.

Income from operations - As a percentage of net sales, income from operations increased by approximately 1% in the third quarter of 2014, and increased by approximately 3% in the first nine months of 2014. These increases were primarily the result of the factors affecting gross margin and operating costs and expenses discussed above.

The key performance indicator for CompX’s reporting units is the level of their income from operations (see discussion below).

	Three months ended September 30,									Nine months ended September 30,
	Three months ended September 30,						%			Nine months ended September 30,						%
	2013			2014			Change			2013			2014				Change
	(In thousands)
Net sales:
Security Products	$	21,457		$	23,237			8	%	$	61,258		$	69,246				13	%
Marine Components		2,752			3,236			18	%		8,443			9,856				17	%
Total net sales	$	24,209		$	26,473			9	%	$	69,701		$	79,102				13	%
Gross margin:
Security Products	$	7,037		$	7,396			5	%	$	19,476		$	22,222				14	%
Marine Components		477			746			56	%		1,668			2,282				37	%
Total gross margin	$	7,514		$	8,142			8	%	$	21,144		$	24,504				16	%
Income from operations:
Security Products	$	4,578		$	4,694			3	%	$	12,245		$	14,235				16	%
Marine Components		(17	)		223			1,412	%		185			729				294	%
Corporate operating expenses		(1,584	)		(1,485	)		6	%		(5,076	)		(4,332	)			15	%
Total income from operations	$	2,977		$	3,432			15	%	$	7,354		$	10,632				45	%
Gross margin:
Security Products		33	%		32	%					32	%		32	%
Marine Components		17	%		23	%					20	%		23	%
Total gross margin		31	%		31	%					30	%		31	%
Income from operations margin:
Security Products		21	%		20	%					20	%		21	%
Marine Components		(1	)%		7	%					2	%		7	%
Total income from operations margin		12	%		13	%					10	%		13	%

Security Products - Security Products net sales increased 8% in the third quarter and 13% in the first nine months of 2014 compared to the same periods last year. The increase in sales for the third quarter and nine month periods is primarily due to increases of approximately $1.1 million and $4.0 million, respectively, in sales of new products for an existing government customer, $1.0 million and $3.3 million, respectively, to transportation market customers due to general improvement in seasonal demand, and $.4 million and $1.8 million, respectively, to electronic lock customers in 2014 due to increased market penetration and two significant project installations

Gross margin in the third quarter of 2014 decreased 1% as compared to the same period in 2013 primarily due to lower variable margins as a result of relative changes in customer and product mix and increased fixed costs. Operating costs and expenses in the third quarter of 2014 increased approximately $.2 million as compared to the third quarter of 2013, primarily as a result of an increase in administrative personnel and benefits costs and increased depreciation during the quarter. As a result, Security Products income from operations as a percentage of net sales in the third quarter of 2014 decreased 1% as compared to the third quarter of 2013. Gross margin for the first nine months of 2014 is comparable to the same period in 2013 as improved coverage of fixed costs over increased production volumes were offset by lower variable margins and increased medical expenses of approximately $.2 million over the nine month period. Additionally, operating costs and expenses for the first nine months of 2014 increased approximately $.8 million, primarily as a result of the increased administrative personnel and benefits costs of approximately $.3 million and increased depreciation of approximately $.2 million during 2014. Security Products income from operations as a percentage of sales for the first nine months of 2014 is comparable to the first nine months of 2013 primarily as a result of factors impacting gross margin and operating costs and expenses discussed above.

Marine Components - Marine Components net sales increased 18% and 17% in the third quarter and first nine months of 2014, respectively, as compared to the same periods last year. The increase in sales is primarily due to gains in market share for products sold to the ski/wakeboard and other non high-performance marine markets. Gross margin and income from operations percentage improved in the third quarter and the first nine months of 2014 compared to the same periods in 2013 primarily due to improved variable margins related to product mix and increased leverage of fixed costs as a result of higher volumes.

Outlook - The robust demand for our products experienced through the first nine months of 2014 has been supported by seasonal influences and high demand from a number of our large government and commercial customers, offset by soft demand from small business customers. In addition, we continue to experience the benefits of diversification in our product offerings and ongoing innovation to serve new markets, most recently with our line of electronic locks for multiple high security applications. While seasonal demand will subside in the fourth quarter, we expect continued strong demand from our large government and commercial customers. As in prior periods, we will continue to monitor general economic conditions and sales order rates and respond to fluctuations in customer demand through continuous evaluation of staffing levels and consistent execution of our lean manufacturing and cost improvement initiatives.

Volatility in the costs of commodity raw materials is expected to continue. Our primary commodity raw materials are zinc, brass and stainless steel, which together represent approximately 11% of our total cost of goods sold. We generally seek to mitigate the impact of fluctuations in commodity raw material costs on our margins through improvements in production efficiencies or other operating cost reductions. In the event we are unable to offset commodity raw material cost increases with other cost reductions, it may be difficult to recover those cost increases through increased product selling prices or surcharges due to the competitive nature of the markets served by our products. Additionally, significant surcharges may negatively affect our margins as they typically only recover the increased cost of the raw material without adding margin dollars resulting in a lower margin percentage. Consequently, overall operating margins may be negatively affected by commodity raw material cost pressures.

Insurance recoveries - We have agreements with certain insurance carriers pursuant to which the carriers reimburse us for a portion of our past lead pigment and asbestos litigation defense costs. Insurance recoveries include amounts we received from these insurance carriers. Substantially all of the $8.8 million insurance recoveries we recognized in the third quarter of 2014 relate to a settlement we reached with one of our insurance carriers in which they agreed to reimburse us for a portion of our past litigation defense costs.

The agreements with certain of our insurance carriers also include reimbursement for a portion of our future litigation defense costs. We are not able to determine how much we will ultimately recover from these carriers for defense costs incurred by us because of certain issues that arise regarding which defense costs qualify for reimbursement. Accordingly, these insurance recoveries are recognized when the receipt is probable and the amount is determinable. See Note 13 to our Condensed Consolidated Financial Statements.

Corporate expense - Corporate expenses were $4.3 million in the third quarter of 2014, $1.3 million lower than in the third quarter of 2013 primarily due to lower litigation and related costs in 2014. Included in corporate expense in the third quarters of 2013 and 2014 are:

Corporate expenses were $17.5 million in the first nine months of 2014, $9.3 million lower than in the first nine months of 2013 primarily due to lower environmental remediation and related costs and litigation and related costs in 2014. Included in corporate expense in the first nine months of 2013 and 2014 are:

The level of our litigation and related costs varies from period to period depending upon, among other things, the number of cases in which we are currently involved, the nature of such cases and the current stage of such cases (e.g. discovery, pre-trial motions, trial or appeal, if applicable). See Note 13 to our Condensed Consolidated Financial Statements. If our current expectations regarding the number of cases in which we expect to be involved during 2014 or the nature of such cases were to change, our corporate expenses could be higher than we currently estimate.

Obligations for environmental remediation costs are difficult to assess and estimate and it is possible that actual costs for environmental remediation will exceed accrued amounts or that costs will be incurred in the future for sites in which we cannot currently estimate our liability. If these events were to occur in 2014, our corporate expenses would be higher than we currently estimate. In addition, we adjust our environmental accruals as further information becomes available to us or as circumstances change. Such further information or changed circumstances could result in an increase in our accrued environmental costs. See Note 13 to our Condensed Consolidated Financial Statements.

Overall, we expect that our general corporate expenses for all of 2014 will be lower than 2013 primarily due to lower expected environmental remediation and related costs. If our current expectations regarding the number of cases or sites in which we expect to be involved during 2014, or if the nature of such cases or sites were to change, our corporate expenses could be higher than we currently estimate and involve amounts that are material.

Income tax expense (benefit) - We recognized an income tax expense of $3.8 million in the third quarter of 2014 compared to an income tax benefit of $3.1 million in the third quarter of 2013, and an income tax expense of $4.6 million in the first nine months of 2014 compared to an income tax benefit of $23.8 million in the first nine months of 2013. The higher income tax expense recognized during 2014 is primarily attributable to equity in earnings of Kronos in 2014 compared to equity in losses of Kronos in 2013. See Note 12 to our Condensed Consolidated Financial Statements for more information about our 2014 income tax items, including a tabular reconciliation of our statutory tax expense (benefit) to our actual expense (benefit).

Noncontrolling interest - Noncontrolling interest in net income of CompX is consistent in the third quarter periods of 2013 and 2014 and increased from $.6 million in the first nine months of 2013 to $.9 million in the first nine months of 2014. The noncontrolling interest we recognize in each period is directly related to the level of earnings at CompX for the period.

	Three months ended September 30,						% Change			Nine months ended September 30,						% Change
	2013			2014			% Change			2013			2014			% Change
	(In millions)
Kronos:
Net sales	$	419.1		$	414.8			(1	)%	$	1,363.8		$	1,278.4			(6	)%
Cost of sales		371.9			319.1			(14	)%		1,303.1			1,008.4			(23	)%
Gross margin	$	47.2		$	95.7			103	%	$	60.7		$	270.0			345	%
Income (loss) from operations	$	(37.0	)	$	47.9			(229	)%	$	(131.6	)	$	118.2			(190	)%
Interest and dividend income		.3			.2			(33	)%		.9			.7			(22	)%
Loss on prepayment of debt		(2.3	)		-			(100	)%		(8.9	)		-			(100	)%
Interest expense		(4.5	)		(3.9	)		(13	)%		(16.6	)		(12.6	)		(24	)%
		(43.5	)		44.2						(156.2	)		106.3
Income tax expense (benefit)		(13.6	)		12.3			(190	)%		(51.3	)		27.0			(153	)%
Net income (loss)	$	(29.9	)	$	31.9					$	(104.9	)	$	79.3
Percentage of net sales:
Cost of sales		89	%		77	%					96	%		79	%
Income (loss) from operations		(9	)%		12	%					(10	)%		9	%
Equity in earnings (loss) of Kronos Worldwide, Inc.	$	(9.1	)	$	9.7					$	(31.9	)	$	24.1
TiO₂ operating statistics:
Sales volumes*		121			125			4	%		397			380			(4	)%
Production volumes*		113			134			18	%		359			388			8	%
Percentage change in TiO₂net sales:
TiO₂product pricing								(6	)%								(5	)%
TiO₂sales volumes								4									(4	)
TiO₂product mix								-									1
Changes in currency exchange rates								1									2
Total								(1	)%								(6	)%

The key performance indicators for Kronos are TiO₂ average selling prices, its level of TiO₂ sales and production volumes and the cost of third-party feedstock ore.

Current industry conditions - As previously discussed, after about a year of decreasing selling prices within the TiO₂industry, Kronos’ TiO₂ selling prices were generally stable during the second half of 2013. Kronos’ average selling prices at the end of the third quarter of 2014 were 7% lower than at the end of 2013, with most of the decline occurring in the first half of the year, and with lower prices in all major markets, most notably in certain export markets. Kronos experienced significantly lower sales to its generally lower-margin export markets in the first half of 2014 compared to the same period of 2013; however, Kronos experienced higher sales in most major markets, including the export markets, in the third quarter of 2014 as compared to the third quarter of 2013. Demand for TiO₂ products has generally been stable in 2014 in most European and North American markets.

Kronos operated its production facilities at reduced capacity rates in 2013 (approximately 92%, 90%, 82% and 81% of practical capacity in the first through fourth quarter periods, respectively). While Kronos’ production capacity utilization rates in the second half of 2013 were impacted by the union labor lockout at its Canadian production facility that ended in December 2013, Kronos’ utilization rates were also impacted by such lockout in the first quarter of 2014, as restart of production at the facility did not begin until February 2014. Kronos operated its production facilities at overall average capacity utilization rates of 96% in the third quarter of 2014, compared to 90% in the first quarter and 97% in the second quarter of 2014.

Kronos’ cost of sales per metric ton of TiO₂ sold in 2013 (particularly in the first quarter) was significantly higher than TiO₂ sold in the first nine months of 2014, as a substantial portion of the TiO₂ products Kronos sold in the first quarter (and to a lesser-extent the second quarter) of 2013 was produced with the higher-cost feedstock ore procured in 2012. Kronos saw moderation in the cost of TiO₂ feedstock ore procured from third parties in 2013 and continuing into 2014, but such reductions did not begin to be significantly reflected in its cost of sales until the third quarter of 2013.

Net sales – Kronos’ net sales in the third quarter of 2014 decreased 1%, or $4.3 million, compared to the third quarter of 2013 primarily due to the net effects of a 6% decrease in average TiO₂ selling prices (which decreased net sales by approximately $25 million) and a 4% increase in sales volumes (which increased net sales by approximately $17 million). Kronos’ net sales in the nine months ended September 30, 2014 decreased 6%, or $85.4 million, compared to the nine months ended September 30, 2013 primarily due to the effects of a 4% decrease in sales volumes (which decreased net sales by approximately $55 million) and a 5% decrease in average TiO₂ selling prices (which decreased net sales by approximately $68 million). TiO₂ selling prices will increase or decrease generally as a result of competitive market pressures, changes in the relative level of supply and demand as well as changes in raw material and other manufacturing costs.

Kronos’ sales volumes increased 4% in the third quarter of 2014 as compared to the third quarter of 2013 due to higher sales primarily in certain export and U.S. markets. Kronos’ sales volumes decreased 4% in the first nine months of 2014 as compared to the first nine months of 2013 primarily due to lower sales in certain export markets. Kronos estimates that changes in currency exchange rates increased Kronos’ net sales by approximately $3 million as compared to the third quarter of 2013 and approximately $23 million as compared to the first nine months of 2013.

Cost of sales – Kronos’ cost of sales decreased $52.8 million or 14% in the third quarter of 2014 compared to 2013 due to the net impact of lower raw materials and other production costs of approximately $50 million (primarily caused by the lower third-party feedstock ore costs, as discussed above), a 4% increase in sales volumes, an 18% increase in TiO₂ production volumes and currency fluctuations (primarily the euro). In addition, in the third quarter of 2013 Kronos recognized approximately $7 million in unabsorbed fixed production costs related to a union labor lockout at Kronos’ Canadian production facility. Cost of sales as a percentage of net sales decreased to 77% in the third quarter of 2014 compared to 89% in the same period of 2013, primarily due to lower raw material costs and lower unabsorbed fixed costs as discussed above.

Kronos’ cost of sales decreased $294.7 million or 23% in the nine months ended September 30, 2014 compared to the same period in 2013 primarily due to the net impact of lower raw materials and other production costs of approximately $235 million (primarily caused by lower third-party feedstock ore costs), an 8% increase in TiO₂ production volumes, a 4% decrease in sales volumes and currency fluctuations (primarily the euro). Cost of sales as a percentage of net sales decreased to 79% in the first nine months of 2014 compared to 96% in the same period of 2013, primarily due to lower raw material costs and the approximately $7 million in unabsorbed fixed production costs related to the union labor lockout at Kronos’ Canadian production facility, as discussed above.

Other operating expense, net – Kronos’ other operating expense in the third quarter of 2013 includes a $35 million litigation settlement charge.

Gross margin and income (loss) from operations – Kronos’ income from operations increased by $84.9 million from a loss of $37.0 million in the third quarter of 2013 to income of $47.9 million in the third quarter of 2014. Income (loss) from operations as a percentage of net sales increased to 12% in the third quarter of 2014 from (9)% in the same period of 2013. This increase was driven by the increase in gross margin, which increased to 23% for the third quarter of 2014 compared to 11% for the third quarter of 2013 and by the third quarter 2013 litigation settlement charge as discussed above. As discussed and quantified above, Kronos’ gross margin increased primarily due to the net effect of lower manufacturing costs (primarily raw materials), higher production volumes, higher sales volumes and lower selling prices. Additionally, changes in currency exchange rates have positively affected Kronos’ gross margin and income from operations. Kronos estimates that changes in currency exchange rates increased income from operations by approximately $8 million in the third quarter of 2014 as compared to the same period in 2013.

Kronos’ income from operations increased by $249.8 million from a loss of $131.6 million in the first nine months of 2013 to income of $118.2 million in the first nine months of 2014. Income (loss) from operations as a percentage of net sales increased to 9% in the first nine months of 2014 from (10)% in the same period of 2013. This increase was driven by the increase in gross margin, which increased to 21% for the first nine months of 2014 compared to 4% for the first nine months of 2013 and by the 2013 litigation settlement charge as discussed above. As discussed and quantified above, Kronos’ gross margin increased primarily due to the net effect of lower manufacturing costs (primarily raw materials), higher production volumes, lower selling prices and lower sales volumes. Additionally, changes in currency exchange rates have positively affected Kronos’ gross margin and income from operations. Kronos estimates that changes in currency exchange rates increased income from operations by approximately $28 million in the first nine months of 2014 as compared to the same period in 2013.

Other non-operating income (expense) - Kronos recognized an aggregate $2.3 million pre-tax charge, consisting of the write-off of unamortized original issue discount costs and deferred financing costs, in the third quarter of 2013 related to the voluntary prepayment of the remaining $100 million principal amount of Kronos’ prior term loan.

Kronos’ interest expense decreased $.6 million from $4.5 million in the third quarter of 2013 to $3.9 million in the third quarter of 2014 primarily due to lower average interest rates on Kronos’ outstanding borrowings in the third quarter of 2014, partially offset by slightly higher average debt levels. Kronos currently expects its interest expense for all of 2014 will be lower than 2013, as the favorable impact of lower average interest rates on outstanding borrowings will offset the impact of higher overall average debt levels resulting from the new term loan Kronos issued in February 2014.

Kronos recognized an aggregate $8.9 million pre-tax charge, consisting of the write-off of unamortized original issue discount costs and deferred financing costs, in the first and third quarters of 2013 related to the voluntary prepayment of Kronos’ prior term loan by $290 million in the first quarter of 2013 and the remaining $100 million in the third quarter of 2013.

Kronos’ interest expense decreased $4.0 million from $16.6 million in the nine months ended September 30, 2013 to $12.6 million in the nine months ended September 30, 2014 primarily due to lower average interest rates on outstanding borrowings in the first nine months of 2014 partially offset by slightly higher average debt levels.

Income tax expense (benefit) - Kronos recognized income tax expense of $12.3 million in the third quarter of 2014 compared to a benefit of $13.6 million in the same period last year. This difference is primarily due to Kronos’ increased earnings.

Kronos recognized income tax expense of $27.0 million in the first nine months of 2014 compared to an income tax benefit of $51.3 million in the same period last year. This difference is primarily due to Kronos’ increased earnings. In addition, Kronos’ income tax expense in the first nine months of 2014 was favorably impacted by an aggregate non-cash income tax benefit of $5.1 million related to a net reduction in Kronos’ reserve for uncertain tax positions.

Kronos has substantial net operating loss carryforwards in Germany (the equivalent of $842 million and $127 million for German corporate and trade tax purposes, respectively, at December 31, 2013) and in Belgium (the equivalent of $102 million for Belgian corporate tax purposes at December 31, 2013). At September 30, 2014, Kronos has concluded that no deferred income tax asset valuation allowance is required to be recognized with respect to such carryforwards, principally because (i) such carryforwards have an indefinite carryforward period, (ii) it has utilized a portion of such German carryforwards during the most recent three-year period and (iii) it currently expects to utilize the remainder of such carryforwards over the long term. However, prior to the complete utilization of such carryforwards, particularly if Kronos were to generate losses in its German and Belgian operations for an extended period of time, it is possible that Kronos might conclude the benefit of such carryforwards would no longer meet the more-likely-than-not recognition criteria, at which point it would be required to recognize a valuation allowance against some or all of the then-remaining tax benefit associated with the carryforwards.

Kronos has substantial operations and assets located outside the United States (primarily in Germany, Belgium, Norway and Canada). The majority of Kronos’ sales from non-U.S. operations are denominated in currencies other than the U.S. dollar, principally the euro, other major European currencies and the Canadian dollar. A portion of Kronos’ sales generated from its non-U.S. operations is denominated in the U.S. dollar. Certain raw materials used worldwide, primarily titanium-containing feedstocks, are purchased in U.S. dollars, while labor and other production costs are purchased primarily in local currencies. Consequently, the translated U.S. dollar value of Kronos’ non-U.S. sales and operating results are subject to currency exchange rate fluctuations which may favorably or unfavorably impact reported earnings and may affect the comparability of period-to-period operating results. In addition to the impact of the translation of sales and expenses over time, Kronos’ non-U.S. operations also generate currency transaction gains and losses which primarily relate to the difference between the currency exchange rates in effect when non-local currency sales or operating costs are initially accrued and when such amounts are settled with the non-local currency.

Overall, Kronos estimates that fluctuations in currency exchange rates had the following effects on its sales and income from operations for the periods indicated.

During the first nine months of 2014 Kronos operated its production facilities at 94% of practical capacity. This reflects an increased plant utilization rate as compared to the same period of 2013. While Kronos’ production capacity utilization rates in the second half of 2013 were impacted by the lockout at its Canadian production facility that ended in December 2013, its utilization rates continued to be impacted by such lockout in the first quarter of 2014, as restart of production at the facility did not begin until February 2014. While Kronos expects its production volumes to be higher in 2014 as compared to 2013, Kronos expects to continue to operate below full production capacity in 2014. The less-than-full production utilization is principally due to the ramp-up of operations at its Canadian facility following the end of the lockout as well as the implementation of certain productivity-enhancing capital improvement projects at other facilities which will result in longer-than-normal maintenance shutdowns in certain instances. Kronos will continue to monitor current and anticipated near-term customer demand levels and align its production and inventories accordingly.

Kronos experienced moderation in the cost of TiO₂ feedstock ore procured in 2013 and continuing into 2014, and consequently its cost of sales per metric ton of TiO₂ sold in the first nine months of 2014 was significantly lower than its cost of sales per metric ton of TiO₂ sold in the first nine months of 2013. Given the time lag between when Kronos procures third-party feedstock ore and when the TiO₂ product produced with such third-party feedstock is sold and recognized in its cost of sales, Kronos expects its cost of sales per metric ton of TiO₂ sold in calendar 2014 will be lower than the cost of sales per metric ton of TiO₂ sold in calendar 2013, and its cost of sales per metric ton of TiO₂ sold in the fourth quarter of 2014 will be lower than the cost of sales per metric ton of TiO₂ sold in the first nine months of 2014. Although the cost of feedstock ore has and continues to moderate, as discussed below, Kronos’ TiO₂ selling prices have declined during 2014. Kronos started 2014 with selling prices 6% lower than the beginning of 2013, and prices declined by an additional 7% in the first nine months of 2014. Industry data indicates that overall TiO₂ inventory held by producers has been significantly decreased. In addition, Kronos believes most customers hold very low inventories of TiO₂ with many operating on a just-in-time basis. As a result, lead times for delivery are increasing. With the strong sales volumes experienced in 2013 and in certain established markets during the first nine months of 2014, Kronos continues to see evidence of improvement in demand for its TiO₂ products in certain of its primary markets. The extent to which Kronos will be able to achieve any price increases in the near term will depend on market conditions.

Overall, Kronos expects that income from operations in 2014 will be higher as compared to 2013, as a result of:

Due to the constraints of high capital costs and extended lead time associated with adding significant new TiO₂ production capacity, especially for premium grades of TiO₂ products produced from the chloride process, Kronos believes increased and sustained profit margins will be necessary to financially justify major expansions of TiO₂ production capacity required to meet expected future growth in demand. As a result of customer decisions over the last year and the resulting adverse effect on global TiO₂ pricing, some industry projects to increase TiO₂ production capacity have been cancelled or deferred indefinitely. Given the lead time required for such production capacity expansions, a shortage of TiO₂ products could occur if economic conditions improve and global demand levels for TiO₂ continue to increase sufficiently.

Kronos’ expectations for its future operating results are based upon a number of factors beyond its control, including worldwide growth of GDP, competition in the marketplace, continued operation of competitors, unexpected or earlier-than-expected capacity additions or reductions and technological advances. If actual developments differ from its expectations, Kronos’ results of operations could be unfavorably affected.

Trends in cash flows from operating activities, excluding the impact of deferred taxes and relative changes in assets and liabilities, are generally similar to trends in our income from operations. Changes in working capital are primarily related to changes in receivables and inventories (as discussed below) and payables and accrued liabilities.

Net cash provided by operating activities was $22.9 million in the first nine months of 2014 compared to $7.4 million in the first nine months of 2013. The $15.5 million net increase in cash provided by operating activities includes the net effects of:

We do not have complete access to CompX’s cash flows in part because we do not own 100% of CompX. A detail of our consolidated cash flows from operating activities is presented in the table below. Intercompany dividends have been eliminated. The reference to NL Parent in the table below is a reference to NL Industries, Inc., as the parent company of CompX and our wholly-owned subsidiaries.

Relative changes in working capital can have a significant effect on cash flows from operating activities. Generally, we expect our average days sales outstanding to increase from December to September as the result of a seasonal increase in sales during the third quarter as compared to the fourth quarter. Overall, our September 30, 2014 days sales outstanding compared to December 31, 2013 is in line with our expectations. As shown below, our total average number of days in inventory relative to sales has been higher in 2014 due to the introduction of new products and due to intentional measures to avoid shortages of certain long lead-time components. For comparative purposes, we have provided information for December 31, 2012 and September 30, 2013 below.

In the first nine months of 2014, we paid $2.2 million in capital expenditures, substantially all of which related to CompX.

During 2013, we paid a regular quarterly dividend to stockholders of $.125 per share. In February 2014, our Board of Directors deferred consideration of a first quarter 2014 cash dividend and no dividend was paid in the first quarter. In May 2014, after considering our results of operations, financial conditions and cash requirements for our businesses, our Board of Directors suspended our regular quarterly dividend. The declaration and payment of future dividends, and the amount thereof, is discretionary and is dependent upon these and other factors deemed relevant by our Board of Directors. The amount and timing of past dividends is not necessarily indicative of the amount or timing of any future dividends which might be paid. There are currently no contractual restrictions on the amount of dividends which we may pay. Distributions to noncontrolling interests consist of CompX dividends paid to shareholders other than us.

At September 30, 2014, NL and CompX did not have any outstanding debt obligations.

The terms of Kronos’ indebtedness contain a number of covenants and restrictions which, among other things, restrict Kronos’ ability to incur additional debt, incur liens, pay dividends or merge or consolidate with, or sell or transfer substantially all of its assets to, another entity, and contains other provisions and restrictive covenants customary in lending transactions of this type. Certain of Kronos’ credit agreements contain provisions which could result in the acceleration of indebtedness prior to their stated maturity for reasons other than defaults for failure to comply with typical financial or payment covenants. For example, certain credit agreements allow the lender to accelerate the maturity of the indebtedness upon a change of control (as defined in the agreement) of the borrower. In addition, certain credit agreements could result in the acceleration of all or a portion of the indebtedness following a sale of assets outside the ordinary course of business. Kronos’ European revolving credit facility also requires the maintenance of certain financial ratios, and one of such requirements is based on the ratio of net debt to the last twelve months EBITDA of the borrowers. In December 2013, the lenders under Kronos’ European revolving credit facility granted a waiver through June 30, 2014 with respect to the financial test, but Kronos’ ability to borrow any amounts under the facility was subject to the requirement that the borrowers maintain a specified level of EBITDA. Kronos met the specified minimum level of EBITDA during the waiver period that ended June 30, 2014. Kronos is in compliance with all of its debt covenants at September 30, 2014. Kronos believes that it will be able to continue to comply with the financial covenants contained in its credit facilities through their maturity; however if future operating results differ materially from its expectations Kronos may be unable to maintain compliance. Kronos believes it has alternate sources of liquidity, including cash on hand and borrowings under its North American revolver, in order to adequately address any compliance issues which might arise. Neither Kronos’ new term loan nor its North American revolving credit facility contains a financial maintenance covenant.

Our primary source of liquidity on an ongoing basis is our cash flow from operating activities and credit facilities with affiliates and banks as further discussed below. We generally use these amounts to (i) fund capital expenditures (substantially all of which relate to CompX), (ii) pay ongoing environmental remediation and litigation costs and (iii) provide for the payment of dividends (if declared).

At September 30, 2014, we had aggregate cash, cash equivalents and restricted cash of $78.0 million, substantially all of which was held in the U.S. A detail by entity is presented in the table below.

In addition, at September 30, 2014 we owned 14.4 million shares of Valhi common stock with an aggregate market value of $93.9 million. See Note 4 to our Condensed Consolidated Financial Statements. We also owned 35.2 million shares of Kronos common stock at September 30, 2014 with an aggregate market value of $485.3 million. See Note 5 to our Condensed Consolidated Financial Statements.

We routinely compare our liquidity requirements and alternative uses of capital against the estimated future cash flows we expect to receive from our subsidiaries and affiliates. As a result of this process, we have in the past and may in the future seek to raise additional capital, incur debt, repurchase indebtedness in the market or otherwise, modify our dividend policies, consider the sale of our interests in our subsidiaries, affiliates, business, marketable securities or other assets, or take a combination of these and other steps, to increase liquidity, reduce indebtedness and fund future activities. Such activities have in the past and may in the future involve related companies.

We periodically evaluate acquisitions of interests in or combinations with companies (including related companies) perceived by management to be undervalued in the marketplace. These companies may or may not be engaged in businesses related to our current businesses. We intend to consider such acquisition activities in the future and, in connection with this activity, may consider issuing additional equity securities and increasing indebtedness. From time to time, we also evaluate the restructuring of ownership interests among our respective subsidiaries and related companies.

Based upon our expectations of our operating performance, and the anticipated demands on our cash resources we expect to have sufficient liquidity to meet our short-term obligations (defined as the twelve-month period ending September 30, 2015). If actual developments differ materially from our expectations, our liquidity could be adversely affected. In this regard, Valhi has agreed to loan us up to $40 million on a revolving basis. At September 30, 2014, we had no outstanding borrowings under this facility, and the full $40 million was available for future borrowing. The amount of any such outstanding loan Valhi would make to us is at Valhi’s discretion. We currently do not expect to be required to borrow any amounts from Valhi during the remainder of 2014 under this facility.

Firm purchase commitments for capital projects in process at September 30, 2014 approximated $.5 million. CompX’s 2014 capital investments are limited to those expenditures required to meet expected customer demand and those required to properly maintain our facilities and technology infrastructure.

Because our operations are conducted primarily through subsidiaries and affiliates, our long-term ability to meet parent company-level corporate obligations is largely dependent on the receipt of dividends or other distributions from our subsidiaries and affiliates. A detail of annual dividends we expect to receive from our subsidiaries and affiliates in 2014, based on the number of shares of common stock of these affiliates we own as of September 30, 2014 and their current regular quarterly dividend rate, is presented in the table below. In May 2014, Valhi’s board of directors reduced its regular quarterly dividend from $.05 per share to $.02 per share, effective with its second quarter 2014 dividend. The amount shown in the table below for Valhi reflects the $.05 per share dividend in the first quarter and $.02 per share dividends we actually received from Valhi in the second and third quarters of 2014, respectively, and $.02 per share we would expect to receive in the fourth quarter of 2014.

We have in the past and may in the future, purchase the securities of our subsidiaries and affiliates or third-parties in market or privately-negotiated transactions. We base our purchase decisions on a variety of factors, including an analysis of the optimal use of our capital, taking into account the market value of the securities and the relative value of expected returns on alternative investments. In connection with these activities, we may consider issuing additional equity securities or increasing our indebtedness. We may also evaluate the restructuring of ownership interests of our businesses among our subsidiaries and related companies.

Other than operating lease commitments discussed in our 2013 Annual Report, we are not party to any material off-balance sheet financing arrangements.

There have been no material changes in our contractual obligations since we filed our 2013 Annual Report and we refer you to that report for a complete description of these commitments.

We are subject to certain commitments and contingencies, as more fully described to our 2013 Annual Report, or in Note 13 to our Condensed Consolidated Financial Statements or in Part II, Item 1 of this report, including certain legal proceedings. In addition to such legal proceedings, various legislation and administrative regulations have, from time to time, been proposed that seek to (i) impose various obligations on present and former manufacturers of lead pigment and lead-based paint (including us) with respect to asserted health concerns associated with the use of such products and (ii) effectively overturn court decisions in which we and other pigment manufacturers have been successful. Examples of such proposed legislation include bills which would permit civil liability for damages on the basis of market share, rather than requiring plaintiffs to prove that the defendant’s product caused the alleged damage and bills which would revive actions barred by the statute of limitations. While no legislation or regulations have been enacted to date that are expected to have a material adverse effect on our consolidated financial position, results of operations or liquidity, enactment of such legislation could have such an effect.

For a discussion of our critical accounting policies, refer to Part I, - “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2013 Annual Report. There have been no changes in our critical accounting policies during the first nine months of 2014.

We are exposed to market risk, including currency exchange rates, interest rates and security prices. There have been no material changes in these market risks since we filed our 2013 Annual Report, and we refer you to Part I, Item 7A. –“Quantitative and Qualitative Disclosure about Market Risk” in our 2013 Annual Report. See also Note 14 to our Condensed Consolidated Financial Statements.

Evaluation of disclosure controls and procedures - We maintain a system of disclosure controls and procedures. The term “disclosure controls and procedures,” as defined by Exchange Act Rule 13a-15(e), means controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit to the SEC under the Securities Exchange Act of 1934, as amended (the “Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information we are required to disclose in the reports we file or submit to the SEC under the Act is accumulated and communicated to our management, including our principal executive officer and our principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions to be made regarding required disclosure. Our management, with the participation of Robert D. Graham, our Vice Chairman of the Board, President and Chief Executive Officer, and Gregory M. Swalwell, our Executive Vice President and Chief Financial Officer, have evaluated the design and effectiveness of our disclosure controls and procedures as of September 30, 2014. Based upon their evaluation, these executive officers have concluded that our disclosure controls and procedures are not effective as of the date of such evaluation because of the material weakness in internal control over financial reporting described below.

Internal control over financial reporting - We also maintain internal control over financial reporting. The term “internal control over financial reporting,” as defined by Exchange Act Rule 13a-15(f), means a process designed by, or under the supervision of, our principal executive and principal financial officers, or persons performing similar functions, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with GAAP, and includes those policies and procedures that:

As permitted by the SEC, our assessment of internal control over financial reporting excludes (i) internal control over financial reporting of equity method investees and (ii) internal control over the preparation of our financial statement schedules required by Article 12 of Regulation S-X. However, our assessment of internal control over financial reporting with respect to equity method investees did include our controls over the recording of amounts related to our investments that are recorded in our Condensed Consolidated Financial Statements, including controls over the selection of accounting methods for our investments, the recognition of equity method earnings and losses and the determination, valuation and recording of our investment account balances.

A material weakness is a deficiency or a combination of deficiencies in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or detected on a timely basis.

Status of Remediation of Material Weakness – As disclosed in our June 30, 2014 Form 10-Q, during the first quarter of 2014, CompX implemented a new enterprise resource planning (“ERP”) system covering financial, production and logistics processes. CompX concluded that, from the date of implementation through June 30, 2014, it did not maintain effective monitoring controls over user access to the new ERP system, which constitutes a material weakness. Specifically, within the new ERP system CompX did not maintain information technology and business process controls over evaluating and monitoring user access rights and transactions processed for appropriate segregation of duties including producing reports to monitor activity related to the appropriateness of access. CompX has taken the following steps to remediate the identified material weakness. Since June 30, 2014, CompX has implemented control procedures, including information technology and business process controls, to address management’s ability to evaluate and effectively monitor user access rights and segregation of duties. CompX believes these additional control procedures have strengthened its internal controls over financial reporting and addressed the material weakness. Testing of the effectiveness of these controls has begun and CompX expects such testing to be completed during the fourth quarter of 2014. Once testing has been completed and CompX concludes that the remediation measures described above are in place and operating effectively, CompX will be able to conclude that the material weakness has been remediated. CompX will continue to test and evaluate these controls as part of our 2014 assessment of internal controls over financial reporting.

Changes in internal control over financial reporting – Other than the implementation of additional control procedures noted above, there have been no changes to our internal control over financial reporting during the quarter ended September 30, 2014 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Refer to Note 13 to our Condensed Consolidated Financial Statements, our 2013 Annual Report, and our Quarterly Report on Form 10-Q for the quarters ended March 31, 2014 and June 30, 2014 for descriptions of certain legal proceedings.

For a discussion of the risk factors related to our businesses, refer to Part I, Item 1A., “Risk Factors,” in our 2013 Annual Report. There have been no material changes to such risk factors during the nine months ended September 30, 2014.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		Page number
Part I.	FINANCIAL INFORMATION

Item 1.	Financial Statements

	Condensed Consolidated Balance Sheets - December 31, 2013; September 30, 2014 (unaudited)	3

	Condensed Consolidated Statements of Operations (unaudited) - Three and nine months ended September 30, 2013 and 2014	5

	Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited) - Three and nine months ended September 30, 2013 and 2014	6

	Condensed Consolidated Statement of Stockholders’ Equity (unaudited) - Nine months ended September 30, 2014	7

	Condensed Consolidated Statements of Cash Flows (unaudited) - Nine months ended September 30, 2013 and 2014	8

	Notes to Condensed Consolidated Financial Statements (unaudited)	10

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	22

Item 3.	Quantitative and Qualitative Disclosure About Market Risk	36

Item 4.	Controls and Procedures	36


Part II.	OTHER INFORMATION

Item 1.	Legal Proceedings	37

Item 1A.	Risk Factors	37

Item 6.	Exhibits	37

	December 31,			September 30,
	2013			2014
	(In thousands)
Trade receivables - CompX	$	8,662		$	11,769
Accrued insurance recoveries		1,877			505
Income taxes receivable from Valhi		54			-
Other receivables		159			152
Refundable income taxes		8			14
Allowance for doubtful accounts		(128	)		(130	)

Total	$	10,632		$	12,310

	December 31,		September 30,
	2013		2014
	(In thousands)
Raw materials	$	3,565	$	3,142
Work in process		6,696		9,671
Finished products		2,974		2,269

Total	$	13,235	$	15,082


	Fair value measurement level	Market value		Cost basis		Unrealized gain
		(In thousands)
December 31, 2013
Valhi common stock	1	$	252,677	$	24,347	$	228,330

September 30, 2014
Valhi common stock	1	$	93,855	$	24,347	$	69,508


	Amount
	(In millions)
Balance at the beginning of the period	$	284.5
Equity in earnings of Kronos		24.1
Dividends received from Kronos		(15.8	)
Other, principally equity in Kronos' other comprehensive loss		(18.7	)

Balance at the end of the period	$	274.1

	December 31, 2013				September 30, 2014
	Carrying		Fair		Carrying		Fair
	Amount		Value		Amount		Value
	(In thousands)
Cash, cash equivalents and restricted cash	$	57,639	$	57,639	$	77,987	$	77,987
Noncontrolling interest in CompX common stock		13,615		23,119		14,283		16,985
NL stockholders' equity		355,380		544,174		263,347		358,306

	Transaction gain/(loss) recognized						Translation gain - impact of rate changes		Total currency impact 2014 vs. 2013
	2013		2014		Change		Translation gain - impact of rate changes		Total currency impact 2014 vs. 2013
	(In millions)
Impact on:
Net sales	$	-	$	-	$	-	$	3	$	3
Income from operations		-		3		3		5		8

	Shares held at September 30, 2014		Current Quarterly Dividend Rate		Annual Expected Dividend
	(in millions)				(in millions)
Kronos		35.2	$	.15	$	21.1
CompX		10.8		.05		2.2
Valhi		14.4		.02		1.6
Total expected annual dividends					$	24.9

31.1	Certification

31.2	Certification

32.1	Certification

101.INS	XBRL Instance Document

101.SCH	XBRL Taxonomy Extension Schema

101.CAL	XBRL Taxonomy Extension Calculation Linkbase

101.DEF	XBRL Taxonomy Extension Definition Linkbase

101.LAB	XBRL Taxonomy Extension Label Linkbase

101.PRE	XBRL Taxonomy Extension Presentation Linkbase

Date: November 7, 2014	/s/ Gregory M. Swalwell
	Gregory M. Swalwell
	(Executive Vice President and Chief Financial Officer, Principal Financial Officer)
Date: November 7, 2014	/s/ Tim C. Hafer
	Tim C. Hafer
	(Vice President and Controller, Principal Accounting Officer)